Maltose Interference-Free Test Strips for Blood Glucose Testing at Point-of-Care: A Laboratory Performance Evaluation

被引:7
|
作者
Ng, Wai-Yoong [1 ]
Tiong, Chiau Chiae [1 ]
Jacob, Edward [1 ]
机构
[1] Singapore Gen Hosp, Dept Pathol, Singapore 169608, Singapore
关键词
ICODEXTRIN;
D O I
10.1089/dia.2010.0095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Maltose interference is a concern with blood glucose testing at point-of-care. We evaluated a maltose interference-free test strip (with a modified recombinant glucose dehydrogenase-pyrroloquinoline quinone system) for the Accu-Chek (R) Performa glucose meter (Roche Diagnostics, Mannheim, Germany). Methods: Blood specimens (n - 120) sent for clinical laboratory glucose testing were used in assessing performance characteristics, including imprecision, linearity, clinical impact analysis, and method comparison, of the test strips. To evaluate sugar interference, two heparinized blood specimens were spiked with maltose, xylose, and galactose (up to 500 mg/dL) followed by testing with modified Performa, Accutrend (R) (Roche Diagnostics), and Advantage II (Roche Diagnostics) test strips and by the laboratory method. Results: Test strips demonstrated total laboratory coefficients of variation of <7%; within-run coefficients of variation were 2.7-5.4% for blood glucose at 2.5-19.7 mmol/L. Clarke Error Grid analysis of the 120 results (0.8-27.6 mmol/L) showed all values to be within critical clinical limits. Comparison with laboratory results gave 0.960 correlation (Spearman's r(2)) with a Deming regression y (Performa) 0.95x (laboratory) - 0.11 mmol/L (SEy vertical bar x0.06 mmol/L). A slight negative bias (-0.5 mmol/L) was demonstrated with the Bland-Altman difference plot. Maltose (up to 13.9 mmol/L) and xylose (33.3 mmol/L) had no effect, but galactose (2.2 mmol/L) showed interference. The sugars also affected test strips for Advantage II but not Accutrend glucose meters. With International Organization for Standardization ISO 15197:2003 criteria, 99% of the 120 results determined by the test strips were within the minimal acceptable performance; only one of 106 (5.9 mmol/L) was >20% from the laboratory result. Conclusions: The modified and improved Performa test strips were not affected by maltose and xylose. They meet ISO 15197:2003 requirements with a slight bias (-0.5 mmol/L) compared to the laboratory method.
引用
收藏
页码:889 / 893
页数:5
相关论文
共 50 条
  • [1] Point-of-Care Testing of Blood Glucose: Clinical Performance and Laboratory Efficiency
    Shih, Wei-Shang
    Yang, Pei-Fang
    Chi, Tzu-Fei
    Huang, Liang Li
    Chen, Chang-I
    Wang, Mei-Xuan
    Ho, Yi-Ting
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2019, 13 (09) : BC10 - BC13
  • [2] Interference-free differential thick-film amperometric glucose sensor for point-of-care testing.
    Yoon, HJ
    Cui, G
    Yoo, JH
    Yoo, J
    Nam, H
    Cha, GS
    CLINICAL CHEMISTRY, 2000, 46 (06) : A61 - A61
  • [3] ECONOMIC EVALUATION OF BLOOD GLUCOSE POINT-OF-CARE TESTING IN THE INTENSIVE CARE UNIT
    Steuten, L. M. G.
    Kip, M.
    Hooijdonk, R.
    Monteban, H.
    Spronk, P.
    Schultz, M.
    VALUE IN HEALTH, 2014, 17 (03) : A250 - A250
  • [4] Utility of point-of-care vs reference laboratory testing for the evaluation of glucose levels
    Andriankaja, O. M.
    Munoz-Torres, F. J.
    Vergara, J. L.
    Perez, C. M.
    Joshipura, K.
    DIABETIC MEDICINE, 2019, 36 (05) : 626 - 632
  • [5] Donald Rumsfeld and point-of-care testing (POCT): the problem of unknown unknownsvenous blood and glucose oxidase-based test strips
    Reynolds, Tim M.
    Pillay, Tahir S.
    JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (10) : 839 - 840
  • [6] Blood Glucose Point-of-Care Testing Quality Assessment and Harmonization With Central Laboratory Assays
    Jacobs, Ellis
    Naskalski, Jerzy W.
    Fogh-Andersen, Niels
    Ritter, Christoph
    Lewenstam, Andrezj
    Maas, Anton
    Mager, Gerard
    Okorodudu, Anthony O.
    POINT OF CARE, 2009, 8 (02): : 82 - 86
  • [7] Point-of-Care Testing in Microbiology The Advantages and Disadvantages of Immunochromatographic Test Strips
    Stuerenburg, E.
    Junker, R.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2009, 106 (04): : 48 - AR1
  • [8] Simultaneous point-of-care testing of blood lipid profile and glucose: Performance evaluation of the GCare Lipid Analyzer
    Kim, Ha Nui
    Yoon, Soo-Young
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (12)
  • [9] Assessment of five portable blood glucose meters, a point-of-care analyzer, and color test strips for measuring blood glucose concentration in dogs
    Cohn, LA
    McCaw, DL
    Tate, DJ
    Johnson, JC
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2000, 216 (02) : 198 - 202
  • [10] Evaluation of the Meritas® BNP Test for Point-of-Care Testing
    Olausson, Johan
    Peterson, Christer
    Bergstrom, Mats
    Larsson, Anders
    CLINICAL LABORATORY, 2015, 61 (07) : 727 - 730